FdaApplication

NDA 205004

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeNDA
approval_date2017-11-06

Products (1)

ProductActive ingredientStrengthDosage form
BORTEZOMIBBORTEZOMIB3.5MG/VIALPOWDER;INTRAVENOUS

1 product